Cargando…

P1442: DYNAMIC LANDSCAPE OF PLASMA PROTEOME AND METABOLOME IN B-ALL PATIENTS DURING CAR-T CELL THERAPY

Detalles Bibliográficos
Autores principales:	Wu, J., Tang, L., Du, M., Li, C., Kou, H., Jiang, H., Luo, W., Zhang, Y., Huang, Z., Xiong, W., Mei, H., Hu, Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Posters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430405/ http://dx.doi.org/10.1097/01.HS9.0000848624.38713.de

Ejemplares similares

Plasma proteomic and metabolomic signatures of B‐ALL patients during CAR‐T cell therapy
por: Wu, Jianghua, et al.
Publicado: (2023)

P1441: SINGLE-CELL TRANSCRIPTOMIC CHARACTERIZATIONS OF BONE MARROW MONONUCLEAR CELLS AND CAR-T PRODUCTS ASSOCIATED WITH EFFICACY AND TOXICITY IN B-ALL PATIENTS
por: Du, M., et al.
Publicado: (2022)

P977: BISPECIFIC CS1-BCMA CAR-T CELLS ARE CLINICALLY ACTIVE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
por: Li, C., et al.
Publicado: (2022)

1442. Acquisition and Transferability Mechanisms of Mercury Resistance Genes in Latin-American Staphylococcus aureus Strains
por: Ortega-Recalde, Oscar, et al.
Publicado: (2020)

P1442: PRACTICE-BASED EVIDENCE: LONG-TERM SAFETY COHORT OF DEFERIPRONE IN PATIENTS WITH SICKLE CELL DISEASE FROM THE US REGISTRY
por: Badawy, Sherif, et al.
Publicado: (2023)

Sphenoid Sinus Diseases: A Review of 1,442 Patients
por: Fooanant, Supranee, et al.
Publicado: (2017)

P871: ISB 1442, A FIRST-IN-CLASS CD38 AND CD47 BISPECIFIC ANTIBODY INNATE CELL MODULATOR FOR THE TREATMENT OF CD38 POSITIVE HEMATOLOGICAL MALIGNANCIES
por: Grandclement, C., et al.
Publicado: (2022)

Benefit-Risk Assessment of Crataegus Extract WS 1442: An Evidence-Based Review
por: Holubarsch, Christian J. F., et al.
Publicado: (2017)

Epidemiology and outcome of 1442 pediatric burn patients: A single-center experience
por: Özlü, Özer, et al.
Publicado: (2022)

Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer
por: An, Rui, et al.
Publicado: (2022)

P1440: BTK INHIBITORS IMPROVE CART19 CELL THERAPY BY MODULATING IMMUNE SYSTEM
por: Luo, W., et al.
Publicado: (2022)

P970: SAFETY AND EFFICACY OF BCMA-CAR-T IMMUNE CELLS DERIVED FROM CORD BLOOD IN THE TREATMENT OF RELAPSED AND REFRACTORY MULTIPLE MYELOMA
por: Wang, Y., et al.
Publicado: (2022)

Dynamic chromatin regulatory landscape of human CAR T cell exhaustion
por: Gennert, David G., et al.
Publicado: (2021)

P1393: BISPECIFIC CD19/CD37 CAR-T CELLS IN PATIENTS WITH REFRACTORY OR RELAPSED B-CELL LYMPHOMA
por: Luo, Wenjing, et al.
Publicado: (2023)

Symptomatic treatment of premenstrual syndrome and/or primary dysmenorrhea with DLBS1442, a bioactive extract of Phaleria macrocarpa
por: Tjandrawinata, Raymond R, et al.
Publicado: (2011)

Nanomechanics and Sodium Permeability of Endothelial Surface Layer Modulated by Hawthorn Extract WS 1442
por: Peters, Wladimir, et al.
Publicado: (2012)

1442. Use of a Spaced-Education Platform to Assess Hand Hygiene Auditor Competency
por: Vaughan-Malloy, Ana M, et al.
Publicado: (2023)

P1385: THE GUIDING SIGNIFICANCE OF IMMUNE CELL SUBSET MONITORING IN IMMUNE RECONSTITUTION IN PATIENTS WITH CAR-T BRIDGED ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
por: zhao, W., et al.
Publicado: (2022)

P1466: CD7 CHIMERIC ANTIGEN RECEPTOR T CELLS FOR ADULT PATIENTS WITH REFRACTORY AND RELAPSED T CELL MALIGNANCIES
por: Zhang, Y., et al.
Publicado: (2022)

P1218: FIRST-IN-HUMAN STUDY OF CD19/BCMA DUAL-TARGETING FAST CAR-T GC012F FOR PATIENTS WITH RELAPSED/REFRACTORY B-CELL NON-HODGKIN’S LYMPHOMA
por: Chen, X., et al.
Publicado: (2022)

Correction: Nanomechanics and Sodium Permeability of Endothelial Surface Layer Modulated by Hawthorn Extract WS 1442
por: Peters, Wladimir, et al.
Publicado: (2013)

P1464: DECREASING HPK1 EXPRESSION IN CD19 CAR-T CELLS: A NOVEL STRATEGY TO OVERCOME CHALLENGES OF CELL THERAPY FOR ADULT (R/R) B-ALL
por: ZHANG, N., et al.
Publicado: (2022)

P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
por: Qu, X., et al.
Publicado: (2022)

P1452: THE PRELIMINARY SAFETY AND EFFICACY STUDY OF SC-U02, A NON-VIRAL GENOME TARGETING, ANTI-CD19 UNIVERSAL CAR-T PRODUCT, IN RELAPSED/REFRACTORY (R/R) DIFFUSE LARGE B-CELL LYMPHOMA PATIENTS
por: Hao, M., et al.
Publicado: (2022)

Systematic exploration of the ciliary protein landscape by large-scale affinity proteomics
por: Boldt, K, et al.
Publicado: (2015)

Proteomic landscape of seminal plasma associated with dairy bull fertility
por: Viana, A. G. A., et al.
Publicado: (2018)

Why does patients’ discharge delay after vertebral augmentation? A factor analysis of 1,442 patients
por: Zhao, He, et al.
Publicado: (2022)

P1361: SLEEPING BEAUTY PLATFORM FOR ENGINEERING CAR-CIK CELLS TOWARD A MULTI-TARGETING STRATEGY IN B-ALL
por: Moretti, Alex, et al.
Publicado: (2023)

P1183: CAR-T MORPHOLOGICAL CHARACTERISTICS AND DYNAMICS IN PERIPHERAL BLOOD, EVALUATED BY A NOVEL MICROSCOPY PLATFORM
por: Fridberg, G., et al.
Publicado: (2022)

Altered plasma proteome during an early phase of an experimental model of peritonitis-induced sepsis
por: Karvunidis, T, et al.
Publicado: (2009)

Crataegus Extract WS®1442 Stimulates Cardiomyogenesis and Angiogenesis From Stem Cells: A Possible New Pharmacology for Hawthorn?
por: Halver, Jonas, et al.
Publicado: (2019)

Analyzing perceptions of a global event using CNN-LSTM deep learning approach: the case of Hajj 1442 (2021)
por: Shambour, Mohd Khaled
Publicado: (2022)

P1417: BASELINE CALCIUM WAS ASSOCIATED WITH PROGNOSIS AFTER CAR T-CELL THERAPY
por: Wang, Xindi, et al.
Publicado: (2023)

Multidimensional Landscape of SA-AKI Revealed by Integrated Proteomics and Metabolomics Analysis
por: Xu, Jiatong, et al.
Publicado: (2023)

P1206: GASTROINTESTINAL BLEEDING SIGNIFICANTLY REDUCED THE EFFICACY AND SURVIVAL OF CD19 CAR-T CELL THERAPY IN PATIENTS WITH GASTROINTESTINAL TRACT INVOLVEMENT OF REFRACTORY/RELAPSED B-CELL LYMPHOMA
por: Ma, L., et al.
Publicado: (2022)

Plasma filtration with dialysis (plasma diafiltration) in critically ill patients with acute liver failure
por: Eguchi, Y, et al.
Publicado: (2014)

P26 LANDSCAPE OF RECURRENT CYTOGENETIC ABNORMALITIES IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AS DETECTED BY CHROMOSOME MICROARRAY ANALYSIS (CMA)
por: Varshavsky Yanovsky, A., et al.
Publicado: (2023)

P1404: IL-10 PLUS THE EASIX SCORE PREDICT BLEEDING EVENTS AFTER ANTI-CD19 CAR T-CELL THERAPY
por: Wang, Xindi, et al.
Publicado: (2023)

P1315: ENGRAFTMENT AND MOBILIZATION OF HUMAN HEMATOPOIETIC STEM/PROGENITOR CELLS ALIGNS WITH DYNAMIC OSCILLATION OF TETRASPANIN CD9
por: Ng, W. H., et al.
Publicado: (2022)

Preclinical and Clinical Applications of Metabolomics and Proteomics in Glioblastoma Research
por: Ahmed, Munazza, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mft58l4if9sb1jb38rdvc0gnrb